Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

===== ===== ===== ===== Year ended Year ended December 31, 2008 December 31, 2007 ----------------- ----------------- GAAP "Adjusted" GAAP "Adjusted" ---- ---------- ---- ---------- Income (Numerator): Net income for basic and diluted EPS $4,196 $4,885 $3,166 $4,804 ====== ====== ====== ====== Shares (Denominator): Weighted-average shares for basic EPS 1,070 1,070 1,117 1,117 Effect of dilutive securities 5 4 (*) 6 4 (*) --- --- --- --- Weighted-average shares for diluted EPS 1,075 1,074 1,123 1,121 ===== ===== ===== ===== Diluted earnings per share $3.90 $4.55 $2.82 $4.29 ===== ===== ===== ===== (*) Dilutive securities used to compute "Adjusted" diluted earnings per share for the three and twelve months ended December 31, 2008 and 2007 were computed exclusive of the methodology used to determine dilutive securities under SFAS No. 123R. Amgen Inc. Product Sales Detail by Product and Geographic Region (In millions) (Unaudited) Three months ended Year ended December 31, December 31,
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 On April 19th ... to supermarkets to search for the growing antibiotic resistant ... Results from a year long study were released late ... foods, specifically meats, over previous years. For those suffering ... growth of antibiotic resistant bacteria in food, may eventually ...
(Date:5/23/2013)... EASTON, Mass. , May 23, 2013 ... today announced that the Company will host a teleconference ... to provide a business update. The teleconference information is ... Time: 11:00 a.m. Eastern Daylight Time (EDT) ... ); (302) 607-2001 (Int,l) Passcode: VS22823 ...
(Date:5/23/2013)... 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE (Europe) approved Total Artificial ... Scotland, which boasts more than 380,000 visitors annually, is ... powered by the Freedom® portable driver as part of ... advanced exhibitions of its kind. , “BodyWorks combines ...
(Date:5/23/2013)... May 23, 2013 Watlow®, an ... complete thermal systems, recently introduced its new catalog, ... of experience in designing and manufacturing industrial heaters, ... products to serve diverse customer needs. , A ... at the beginning of the book. These options ...
Breaking Biology Technology:Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Watlow Introduces Its New Industrial Heater Catalog 2
... 15 BioMed Realty Trust, Inc.,(NYSE: BMR ) today ... 2008 dividend of $0.335 per share of common stock. The,dividend ... share., BioMed also announced that its board of directors ... 7.375% Series A Cumulative,Redeemable Preferred Stock for the period from ...
... division of Nycomed,US Inc., today announced the FDA ... formulation compares to Taro,s Referenced Listed Drug (RLD),and ... # 0168-0133-15), 30g tubes,(NDC # 0168-0133-30) and 45g ... Clotrimazole Cream is another illustration of,Fougera,s robust product ...
... HAYWARD, Calif., Sept. 12 Acologix, Inc., a ... two,preclinical studies demonstrating that AC-100, its therapeutic product,candidate ... bone and,dental cells, promotes cartilage regeneration in large ... Catherine A. Middleton-Hardie on September,13, 2008 at the ...
Cached Biology Technology:BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting 2Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting 3
(Date:5/23/2013)... (May 23, 2013) A new report from ... for helping pupils engage in at least 60 minutes ... day. , No more than half of American youth ... of vigorous or moderate intensity physical activity daily, according ... "Because children are in school for nearly half of ...
(Date:5/23/2013)... Publishing in Neuron , the team reveal the ... in work funded by the Wellcome Trust and BBSRC. ... external stimuli we improve our perceptual abilities. While these ... they can also affect the fidelity of that response. ... Visual Neuroscience explains: "When you communicate with others, you ...
(Date:5/22/2013)... to improve durability in fuel cell powered buses, ... discovered links between electrode degradation processes and bus ... effects of electrode degradation stressors in the operating ... , The findings of the study, led by ... in a long-term study at Burnaby-based Ballard Power ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2Tests lead to doubling of fuel cell life 2
... biochemistry is how proteins recognize "correct" interaction partners in ... critical to know than in the brain, where interactions ... A team of biologists at the Salk Institute for ... regulates availability of a brain channel that modulates neuronal ...
... March 22, 2011 BGI (previously known as the ... world, announced its participation and pivotal role in the ... systematically determine the functional and evolutionary diversity of microbial ... planet and mankind. Unlike past microbial studies ...
... are transfused in the US every year. Routine blood screening ... C, HIV types 1 and 2, and syphilis, but not ... to chronic fatigue syndrome. A symposium at the New York ... in the testing and screening of the blood supply, diagnose ...
Cached Biology News:Salk scientists crack molecular code regulating neuronal excitability 2Salk scientists crack molecular code regulating neuronal excitability 3BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 2BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 3BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 4
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
MDMA Mouse Monoclonal Antibody (Clone 3G8)...
... Immunogen: ... region encompassing the human, mouse, ... Accession Number: ... Assurance: Routinely evaluated by ...
TTC4 Antibody...
Biology Products: